United Kingdom · Question · Written question
UIN 56497
Fampridine
Original
Introduced
15 October 2021
Last action
28 October 2021 · Answer
Status
Answered
Sponsors
—
Subjects
Discovery layer
Source updated
28 October 2021
Summary
To ask the Secretary of State for Health and Social Care, what recent assessment has made of the potential merits of using fampridine for the treatment of multiple sclerosis.
This text is taken from the official record. PoliticalRepo does not editorialize.
Timeline
15 October 2021
Written question
To ask the Secretary of State for Health and Social Care, what recent assessment has made of the potential merits of using fampridine for the treatment of multiple sclerosis.
Source: Commons
28 October 2021
Answer
The Department has made no assessment. The National Institute for Health and Care Excellence (NICE) is the independent body responsible for developing evidence-based guidance for the National Health Service on whether medicines represent a clinical and co...
Source: Written answer
Votes
No vote records are attached yet.
Versions
No version snapshots stored. Document URLs remain at the source.
Documents
No documents linked.
Sponsors
- · Department of Health and Social Care · Answering body
Related records
No cross-record relationships stored yet.
Sources
PoliticalRepo is an index and interpretation layer, not the authoritative legal source.
- Official source: https://questions-statements.parliament.uk/written-questions/detail/2021-10-15/56497
- Open data entity: https://questions-statements-api.parliament.uk/api/writtenquestions/questions/1359532
- uk · wq-1359532 · source updated 28 October 2021